Li, Y.; Gong, Q.; Guo, W.; Kan, X.; Xu, D.; Ma, H.; Fu, S.; Liu, J.
Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway. Int. J. Mol. Sci. 2018, 19, 1770.
https://doi.org/10.3390/ijms19061770
AMA Style
Li Y, Gong Q, Guo W, Kan X, Xu D, Ma H, Fu S, Liu J.
Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway. International Journal of Molecular Sciences. 2018; 19(6):1770.
https://doi.org/10.3390/ijms19061770
Chicago/Turabian Style
Li, Yanwei, Qian Gong, Wenjin Guo, Xingchi Kan, Dianwen Xu, He Ma, Shoupeng Fu, and Juxiong Liu.
2018. "Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway" International Journal of Molecular Sciences 19, no. 6: 1770.
https://doi.org/10.3390/ijms19061770
APA Style
Li, Y., Gong, Q., Guo, W., Kan, X., Xu, D., Ma, H., Fu, S., & Liu, J.
(2018). Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway. International Journal of Molecular Sciences, 19(6), 1770.
https://doi.org/10.3390/ijms19061770